David J. Nagel
-
- Phosphodiesterase function and regulation 4
- Redox biology and oxidative stress 2
-
- Cell Adhesion Molecules Research 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
- Pulmonary Hypertension Research and Treatments 5
- Medical Imaging and Pathology Studies 4
-
- HER2/EGFR in Cancer Research 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Yan ChenGuoyong YinYujun CaiNing ZhangR.M. KottmannPeter A. KnightBradford C. BerkClint L. Miller
- Partner nations
- United StatesChinaJapan
In The Last Decade
David J. Nagel
19 papers receiving 550 citations
Peers
Comparison fields: 5 of 80
- Cardiology and Cardiovascular Medicine 148
- Molecular Biology 379
- Immunology and Allergy 21
- Pharmacology 58
- Physiology 85
Countries citing papers authored by David J. Nagel
This map shows the geographic impact of David J. Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Nagel more than expected).
Fields of papers citing papers by David J. Nagel
This network shows the impact of papers produced by David J. Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Nagel. The network helps show where David J. Nagel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David J. Nagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 16 | |
| 9 | 2019 | 1 | |
| 10 | 2018 | 48 | |
| 11 | 2015 | 81 | |
| 12 | 2014 | 1 | |
| 13 | 2010 | 21 | |
| 14 | 2010 | 37 | |
| 15 | 2009 | 22 | |
| 16 | 2009 | 138 | |
| 17 | 2008 | 20 | |
| 18 | 2007 | 30 | |
| 19 | 2006 | 92 | |
| 20 | 2005 | 1 |
About David J. Nagel
David J. Nagel is a scholar working on Immunology and Allergy, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 21 papers that have together received 559 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Pulmonary Hypertension Research and Treatments (5 papers), Phosphodiesterase function and regulation (4 papers), Medical Imaging and Pathology Studies (4 papers), Cell Adhesion Molecules Research (2 papers), Redox biology and oxidative stress (2 papers), HER2/EGFR in Cancer Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (148 citations), Molecular Biology (379 citations) and Immunology and Allergy (21 citations). David J. Nagel has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Yan Chen, Guoyong Yin, Yujun Cai, Ning Zhang, R.M. Kottmann, Peter A. Knight, Bradford C. Berk, Clint L. Miller, Pingjin Gao and Patricia J. Sime. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.